A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
Clinical trial NCT07527169 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07527169
- Sponsor
- M.D. Anderson Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-07-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.